{
    "Trade/Device Name(s)": [
        "First Sign Multi-Drug Dip Card Test",
        "First Sign Multi-Drug Cup Test",
        "First Sign Drug of Abuse Dip Card Test Marijuana",
        "First Sign Drug of Abuse Cup Test Marijuana"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K171695",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "LDJ",
        "NFY",
        "NGG"
    ],
    "Summary Letter Date": "February 5, 2018",
    "Summary Letter Received Date": "December 28, 2017",
    "Submission Date": "December 26, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Cocaine",
        "Methamphetamine",
        "Marijuana"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic assay",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry",
        "Lateral flow chromatographic immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Multi-Drug Dip Card Test, Cup Test, and Drug of Abuse tests for marijuana, amphetamine, cocaine, and methamphetamine in urine using lateral flow immunoassay.",
    "Indications for Use Summary": "Qualitative detection of amphetamine, cocaine, and methamphetamine (multi-drug tests, OTC) and marijuana (marijuana tests, prescription use only) in human urine as an in vitro diagnostic, providing preliminary results requiring confirmation.",
    "fda_folder": "Toxicology"
}